You are here

Cosentyx

Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med

Fierce Pharma

Tue, 03/21/17 - 10:00 am

Valeant Pharmaceuticals

Are DTC ads tipping the balance in psoriasis battle between Lilly’s Taltz and Novartis’ Cosentyx?

Fierce Pharma

Mon, 12/5/16 - 10:10 am

DTC advertising

Drug Makers Target Psoriatic Arthritis

Investopedia

Thu, 11/17/16 - 04:44 pm

psoriatic arthritis

Eli Lilly’s new psoriasis treatment Taltz launches first ads, chasing Novartis’ Cosentyx lead

Fierce Pharma

Wed, 10/12/16 - 11:33 am

Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison

BioPharma Dive

Mon, 03/7/16 - 10:00 pm

Novartis' psoriasis mega-blockbuster hopeful Cosentyx nabs 2 new indications

BioPharma Dive

Tue, 01/19/16 - 10:41 am

psoriatic arthritis

ankylosing spondylitis

Novartis' Cosentyx price sets the stage for psoriasis battle

Fierce Pharma Marketing

Mon, 11/30/15 - 10:28 am

Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses

Yahoo/Market Realist

Sun, 11/29/15 - 12:27 pm

ankylosing spondylitis

psoriatic arthritis

Novartis snags new approvals for Cosentyx in Europe

Fierce Pharma

Tue, 11/24/15 - 09:49 am

Novartis wins European recs for a pair of new Cosentyx uses

Fierce Pharma

Fri, 10/23/15 - 11:09 am

psoriatic arthritis

ankylosing spondylitis

Novartis stacks up more data for lucrative Cosentyx expansion

Fierce Pharma

Thu, 10/1/15 - 02:08 pm

J&J's Stelara may be under fire in psoriasis, but it's positioned to score elsewhere

Fierce Pharma Marketing

Fri, 07/24/15 - 05:59 pm

New data fuel hopes for broad use of Novartis psoriasis drug

Yahoo/Reuters

Mon, 06/29/15 - 10:46 am

Novartis zeroes in on costs as blockbusters-to-be Cosentyx, Entresto rev up

Fierce Pharma

Thu, 06/18/15 - 11:10 am

Roche, Novartis and Bayer snag NICE OKs

Fierce Pharma

Tue, 06/2/15 - 04:50 pm

11 promising drugs poised to be the next billion-dollar blockbusters

Yahoo/Business Insider

Sat, 03/28/15 - 10:26 am

Psoriasis data wars heat up at AAD with Novartis, Boehringer studies

Fierce Pharma Marketing

Thu, 03/26/15 - 07:38 am

Boehringer Ingelheim

Here comes the blockbuster: Novartis' Cosentyx bests Stelara in psoriasis trials

BioPharma Dive

Mon, 03/23/15 - 10:36 am

Novartis AG (ADR) Cosentyx More Effective Than Johnson & Johnson Stelara

Bidness Etc.

Sat, 03/14/15 - 03:04 pm

Novartis psoriasis drug approval could upend market

Medical Marketing and Media

Thu, 01/22/15 - 09:55 am

Pages